Asian Journal of Research in Chemistry

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Stability Indicating RP-HPLC Method for the Determination of Tolterodine Tartrate in Bulk as well as in Pharmaceutical formulation


Affiliations
1 A.K.R.G College of Pharmacy, Nallajerla, West Godavari, 534112, A.P
2 Prof. Pharmaceutical Analysis, Yalamarty College of Pharmacy, Tarluwada Visakhapatnam, 530052, A.P
     

   Subscribe/Renew Journal


Objective: A new rapid, simple, sensitive, selective and accurate reversed-phase stability indicating HPLC method was developed for the determination of Tolterodine Tablets 2mg. Tolterodine Tartrate used in the treatment of urinary incontinence. Method: A RP-HPLC method was developed for method development, validation as well as for the stability indication. The process was achieved using a RP-High performance liquid chromatography equipped with Auto Sampler and DAD or UV detector and the column used for process was Symmetry C18 (4.6 x 150mm, 5 μm, Make: Kromosil). The mobile phase was consists of Phosphate Buffer (with pH 3.0) and Acetonitrile [HPLC grade]. The binary gradient was made with a flow rate at 0.8 ml/min. The detection wavelength was selected 282 nm. The injection volume was 20 μL. Results: The Accuracy was calculated and the % Recovery was found to be 98.1%to 100.2%. The method was found to be Linear over the range of 20 to 100μg per ml. The LOD for the drug was found to be 0.108μg/ml and LOQ for Tolterodine Tartrate was found to be 0.36μg/mL. The drug undergoes degradation under Acidic, Basic, Photochemical, Thermal and Oxidation. All the peaks of the degraded products were resolved from the active Pharmaceutical Ingredient with significantly different retention time. Conclusion: The validated method yielded good results of precision, linearity, accuracy, and robustness. The proposed method was found to be suitable and accurate for the method development and validation and assay of compound Tolterodine Tartrate in active pharmaceutical ingredient. The developed method was validated to ensure the compliance in accordance with ICH guidelines and also well suitable for studies on HPLC. The method was reproducible and selective for the estimation of Tolterodine Tartrate. Because the method could effectively separate the drug from its degradation products, it was employed as a stability-indicating one.

Keywords

High performance liquid chromatography, Assay, Validation, Limit of Quantification (LOQ), Tolterodine Tartrate, Limit of Detection (LOD), ICH guideline, Stability Indicating
Subscription Login to verify subscription
User
Notifications
Font Size


  • http://en.wikipedia.org/wiki/Tolterodine

  • http://www.rxlist.com/detrol-la-drug.htm

  • National center of Biotechnology information. Available at: http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001025/ (access on April 2012).

  • ICH Harmonized Tripartite Guideline on validation of Analytical Procedures: Q 2 (R1) (2005).

  • United States Pharmacopeia Asian edition (2005).

  • Supriya M Mhamunkar, Roshani Y. Vyavaharkar and Suvarna I Bhoir; RP-HPLC Method Development and Validation for the Simultaneous Estimation of Tamsulosin HCL and Tolterodine Tartrate in pharmaceutical dosage form; Int J Pharm Pharm Sci. 2012; 4 Suppl 5:320-322.

  • Dwibhashyam V.S, Keerthi P, Ratna J. V, Nagappa A. N; Reverse-Phase High performance liquid chromatographic method for the determination of Tolterodine Tartrate in routine quality control samples. PDA J Pharm Sci Technol.2009; 63(3):234- 239.

  • S Radha Krishna, B.M. Rao and N. Someswara Rao, A Validated Stability-Indicating HPLC Method for the Determination of Related Substances and Assay of Tolterodine Tartrate. Rasayan J. Chem.2009; 2(1):144-150.

  • S. Ashutosh Kumar, Manidipa Debnath, J.V.L.N.Seshagiri Rao, Method Development and Validation of Tolterodine Tartrate in Bulk as well as in Pharmaceutical Formulation by Using RPHPLC; Int J Pharm Pharm Sci, Vol 5, Issue 3, 665-671.

  • Sethi, P.D., In; HPLC ‘High Performance Liquid Chromatography’, Quantitative Analysis of Pharmaceutical Formulations, 1st Edn; CBS Publishers and Distributors, New Delhi, 2001, 3-72,116-120.

  • Indian Pharmacopeia 2007, Volume I: The Indian Pharmacopoeia Commission, 477-478.

  • Yuri Kazakevich and Rosario Lobrutto Seton: HPLC for Pharmaceutical Scientists 1st ed, Wiley-VCH; 2007; 369-382.

  • Stavros Kromidas. HPLC Made to Measure, A Practical Book for Optimization. Published by Wiley-VCH; 2006; 62-66.

  • Yuri Kazakevich and Rosario Lobrutto Seton: HPLC for Pharmaceutical Scientists.1st ed, Wiley-VCH; 2007; 389-391.

  • International Conference on Harmonization (ICH). Topic Q2 (R1). Validation of analytical procedures: Text and Methodology. Geneva, Switzerland November 2005.

  • Sharma B. K.; Instrumental Method of Chemical Analysis, 21th Edition, Goel Publishing Housing, Krishna Prakashan Ltd., 2002; 3.

  • Skoog, West and Holler; Fundamental of Analytical Chemistry, 7th Edition, Saunders college Publishing, 1992.

  • Conners K. A.; Textbook of Pharmaceutical Analysis, 3 rd Edition, A Wiley- Intersciences Publication, 1999; 616-622.

  • ICH harmonized tripartite guideline. Impurities in New Drug products Q3B (R2) current step 4 version dated 2 June 2006.

  • ICH, Q1A (R2), Stability Testing of New Drug Substances and Products, Geneva, Feb.2003.


Abstract Views: 437

PDF Views: 2




  • Stability Indicating RP-HPLC Method for the Determination of Tolterodine Tartrate in Bulk as well as in Pharmaceutical formulation

Abstract Views: 437  |  PDF Views: 2

Authors

S. Ashutosh Kumar
A.K.R.G College of Pharmacy, Nallajerla, West Godavari, 534112, A.P
Manidipa Debnath
A.K.R.G College of Pharmacy, Nallajerla, West Godavari, 534112, A.P
J.V.L.N. Seshagiri Rao
Prof. Pharmaceutical Analysis, Yalamarty College of Pharmacy, Tarluwada Visakhapatnam, 530052, A.P

Abstract


Objective: A new rapid, simple, sensitive, selective and accurate reversed-phase stability indicating HPLC method was developed for the determination of Tolterodine Tablets 2mg. Tolterodine Tartrate used in the treatment of urinary incontinence. Method: A RP-HPLC method was developed for method development, validation as well as for the stability indication. The process was achieved using a RP-High performance liquid chromatography equipped with Auto Sampler and DAD or UV detector and the column used for process was Symmetry C18 (4.6 x 150mm, 5 μm, Make: Kromosil). The mobile phase was consists of Phosphate Buffer (with pH 3.0) and Acetonitrile [HPLC grade]. The binary gradient was made with a flow rate at 0.8 ml/min. The detection wavelength was selected 282 nm. The injection volume was 20 μL. Results: The Accuracy was calculated and the % Recovery was found to be 98.1%to 100.2%. The method was found to be Linear over the range of 20 to 100μg per ml. The LOD for the drug was found to be 0.108μg/ml and LOQ for Tolterodine Tartrate was found to be 0.36μg/mL. The drug undergoes degradation under Acidic, Basic, Photochemical, Thermal and Oxidation. All the peaks of the degraded products were resolved from the active Pharmaceutical Ingredient with significantly different retention time. Conclusion: The validated method yielded good results of precision, linearity, accuracy, and robustness. The proposed method was found to be suitable and accurate for the method development and validation and assay of compound Tolterodine Tartrate in active pharmaceutical ingredient. The developed method was validated to ensure the compliance in accordance with ICH guidelines and also well suitable for studies on HPLC. The method was reproducible and selective for the estimation of Tolterodine Tartrate. Because the method could effectively separate the drug from its degradation products, it was employed as a stability-indicating one.

Keywords


High performance liquid chromatography, Assay, Validation, Limit of Quantification (LOQ), Tolterodine Tartrate, Limit of Detection (LOD), ICH guideline, Stability Indicating

References